Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,252 across all filing types
Latest filing 2014-09-29 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
对外投资进展公告
Capital/Financing Update Classification · 95% confidence The document is titled '对外投资进展公告' which translates to 'Announcement of External Investment Progress'. It details the establishment of a wholly-owned subsidiary by the company, including registration details, business scope, and capital commitments. The document is an announcement about the progress of an investment project rather than a financial report, management discussion, or regulatory filing. It does not contain financial statements or detailed financial analysis. The document length is short (1362 characters), and it is clearly an announcement of a corporate action related to investment progress. This fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including establishment of subsidiaries and investment projects.
2014-09-29 Chinese
北京国枫凯文律师事务所关于公司调整预留限制性股票授予对象及授予数量的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding adjustments to the reserved restricted stock grant recipients and quantities for a company. It references legal compliance with company law, securities law, and stock incentive management regulations. The document is a standalone legal opinion related to a stock incentive plan adjustment, not a financial report, earnings release, or regulatory announcement. It does not contain financial statements or earnings data. It is not a report publication announcement or certification letter but a legal opinion on a corporate action. Therefore, it fits best under Regulatory Filings (RNS) as a miscellaneous legal compliance document that does not fit other specific categories.
2014-09-24 Chinese
预留部分限制性股票授予人员名单（调整后）
Remuneration Information Classification · 95% confidence The document is a detailed list of individuals receiving reserved restricted stock awards, specifying the number of shares granted, their roles, and departments. It focuses on stock incentive allocation to middle management and core technical personnel. There is no indication of financial statements, audit information, meeting materials, voting results, or regulatory announcements. The content is about share-based compensation details, which aligns with disclosures related to remuneration or compensation information for executives and key employees. Therefore, the document fits best under Remuneration Information (DEF 14A). The document length is short and does not indicate it is an announcement of a report but rather the actual list of recipients and share grants.
2014-09-24 Chinese
关于预留部分限制性股票完成授予登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of registration for the granting of reserved restricted shares under a stock incentive plan. It details the number of shares granted, the price, the recipients, the unlocking schedule, and the impact on the company's capital structure. It also references a verification report by an accounting firm but does not contain comprehensive financial statements or detailed financial performance data. The document is relatively short (2987 characters) and focuses on the completion of a specific share grant event rather than presenting a full financial report or management discussion. This fits the category of a Regulatory Filing (RNS) as it is a formal announcement about share incentive registration and capital changes but not a full capital change announcement (SHA) or a management report. Therefore, the best classification is Regulatory Filings (RNS).
2014-09-24 Chinese
《公司章程》修订对照说明
Governance Information Classification · 95% confidence The document is a formal announcement from the company's board regarding amendments to the company's Articles of Association (公司章程). It details specific changes to the company's registered capital and share structure, approved at a board meeting. There is no financial data, no mention of annual or interim reports, no voting results, no executive changes, and no regulatory certifications. The document is a regulatory announcement about governance documents, specifically the company's bylaws or articles of association. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules and governance practices.
2014-09-19 Chinese
对外投资公告
Capital/Financing Update Classification · 95% confidence The document is titled '对外投资公告' which translates to 'External Investment Announcement'. It details the company's plan to establish a wholly-owned subsidiary with an investment of 200 million RMB, including board approval and risk analysis. The document is an announcement of a corporate investment decision rather than a financial report or detailed financial data. It does not contain financial statements, earnings data, or regulatory certifications. It is not a report publication announcement since it contains substantive information about the investment decision itself. The content fits best under Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through establishing a new subsidiary.
2014-09-19 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.